1. Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm;Deedwania;Am J Med,2005
2. Continuous subcutaneous insulin infusion (CSII) in treating young diabetic patients;Buczkowska;Przegl Lek,2005
3. An assessment of the variability in the pharmacodynamics (glucose lowering effect) of HOE901 compared to NPH and ultralente human insulins using the euglycaemic clamp technique (Abstr 882);Scholtz;Diabetologia,1999
4. Insulin Pharmacokinet;Binder;Diabetes Care,1984
5. Complications of insulin infusion pump therapy;Bending;JAMA,1985